Gestational Diabetes in Women with Fetal Spina Bifida Repair-Influence of Perioperative Management

被引:0
|
作者
Ruegg, Ladina [1 ,2 ]
Vonzun, Ladina [1 ,2 ,3 ]
Zepf, Julia [1 ,2 ]
Strubing, Nele [1 ,2 ,3 ]
Mohrlen, Ueli [2 ,3 ,4 ,5 ,6 ]
Mazzone, Luca [2 ,3 ,4 ,5 ,6 ]
Meuli, Martin [2 ,5 ,6 ]
Ochsenbein-Kolble, Nicole [1 ,2 ,3 ]
机构
[1] Univ Hosp Zurich, Dept Obstet, Ramistr 100, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Fac Med, Ramistr 71, CH-8006 Zurich, Switzerland
[3] Univ Zurich, Zurich Ctr Fetal Diag & Therapy, CH-8006 Zurich, Switzerland
[4] Univ Childrens Hosp Zurich, Dept Pediat Surg, Steinwiesstr 75, CH-8032 Zurich, Switzerland
[5] Univ Childrens Hosp Zurich, Spina Bifida Ctr, Steinwiesstr 75, CH-8032 Zurich, Switzerland
[6] Univ Childrens Hosp Zurich, Childrens Res Ctr, Steinwiesstr 75, CH-8032 Zurich, Switzerland
关键词
fetal surgery; spina bifida; fetal myelomeningocele repair; gestational diabetes; steroids; tocolytics; PREGNANCY OUTCOMES; PHYSICAL-ACTIVITY; RISK; MELLITUS; SURGERY; OBESITY;
D O I
10.3390/jcm13175029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Objectives: Fetal spina bifida (fSB) is the most common neural tube defect, and intrauterine repair has become a valid treatment option for selected cases. If fSB repair is offered, the ideal time for surgery is from 24 to 26 gestational weeks (GWs). The preoperative steroids for lung maturation and preoperative tocolytics that are administered are known to increase the prevalence of gestational diabetes (GD), which normally occurs in about 10-15% of all pregnant women. This study assessed the prevalence, possible influencing factors, and consequences on the course of pregnancy regarding GD in this cohort. Methods: Between 2010 and 2022, 184 fSB cases were operated. Those patients operated on after 24 0/7 GWs received steroids before surgery. All the patients received tocolysis, and an oral glucose tolerance test was performed between 26 and 28 GWs at least 7 days after steroid administration. In 2020, we established an early postoperative mobilization protocol. The perioperative management procedures of those patients with and without GD were compared to each other, and also, the patients treated according to the early mobilization protocol were compared to the remaining cohort. Results: Nineteen percent were diagnosed with GD. Corticosteroids were administered in 92%. Neither the corticoid administration nor the interval between the administration and glucose tolerance test was different in patients with or without GD. Further, 99.5% received postoperative tocolytics for at least 48 h. The women with GD had significantly longer administration of tocolytics. The length of stay (LOS) was higher in those patients with GD. The gestational age (GA) at delivery was significantly lower in the cohort with GD. In the early mobilized group, we found a significantly higher GA at delivery (37.1 GWs vs. 36.2 GWs, p = 0.009) and shorter LOS (p < 0.001), and their GD rate was lower (10% vs. 20%), although not statistically significant. Conclusions: The GD incidence in the women after fSB repair was higher than in the usual pregnant population. Early mobilization, rapid tocolytics decrease, and shorter LOS could benefit the pregnancy course after fSB repair and may decrease the risk for GD in this already high-risk cohort without increasing the risk for preterm delivery.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] The Experience of Self-Management in Adolescent Women with Spina Bifida
    Sawin, Kathleen J.
    Bellin, Melissa H.
    Roux, Gayle
    Buran, Constance F.
    Brei, Timothy J.
    REHABILITATION NURSING, 2009, 34 (01) : 26 - 38
  • [22] Influence of fetal sex on perinatal outcomes in women with gestational diabetes mellitus
    Hu, Jun
    Ge, Zhijuan
    Xu, Qianyue
    Shen, Shanmei
    Wang, Yanmei
    Zhu, Dalong
    Bi, Yan
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (03)
  • [23] Urological Outcome after Fetal Spina Bifida Repair: Data from the Zurich Cohort
    Mazzone, Luca
    Holscher, Alice Catherine
    Moehrlen, Ueli
    Gobet, Rita
    Meuli, Martin
    Horst, Maya
    FETAL DIAGNOSIS AND THERAPY, 2020, 47 (12) : 882 - 888
  • [24] Global Policy and Practice for Intrauterine Fetal Resuscitation During Fetal Surgery for Open Spina Bifida Repair
    Gallagher, Katie
    Crombag, Neeltje
    Prashar, Kavita
    Deprest, Jan
    Ourselin, Sebastien
    David, Anna L.
    Marlow, Neil
    JAMA NETWORK OPEN, 2023, 6 (04) : e239855
  • [25] Outcome of fetal microneurosurgery for intrauterine spina bifida repair in country with deficient healthcare system
    Sosa, C.
    Rivas, M.
    Mascareno, P.
    Amarilla, L.
    Ricardo, A.
    Rojas, M.
    Gonzalez, J.
    Sosa, P.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2022, 59 (01) : 120 - 122
  • [26] The influence of management of gestational diabetes mellitus to the incidence of fetal macrosomia.
    Shi, CY
    Yang, HX
    Xie, CY
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 91A - 91A
  • [27] Parental Management Choices and Discordant Ultrasound Findings in Referrals for Fetal Spina Bifida
    Van den Eede, Emma
    Vergote, Simen
    Van der Veeken, Lennart
    Russo, Francesca
    Van der Merwe, Johannes
    Mastrodima-Polychroniou, Sofia
    De Catte, Luc
    Deprest, Jan
    PRENATAL DIAGNOSIS, 2024,
  • [28] Clinical and Histologic Evaluation of the Hysterotomy Site and Fetal Membranes after Open Fetal Surgery for Fetal Spina Bifida Repair
    Ochsenbein-Kolble, Nicole
    Brandt, Simone
    Bode, Peter
    Krahenmann, Franziska
    Husler, Margaret
    Mohrlen, Ueli
    Mazzone, Luca
    Meuli, Martin
    Zimmermann, Roland
    FETAL DIAGNOSIS AND THERAPY, 2019, 45 (04) : 248 - 255
  • [29] Contemporary management considerations of urinary tract infections for women with spina bifida
    Fremion, Ellen
    Bustillos, Paola
    Khavari, Rose
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2022, 33 (03) : 493 - 505
  • [30] Contemporary management considerations of urinary tract infections for women with spina bifida
    Ellen Fremion
    Paola Bustillos
    Rose Khavari
    International Urogynecology Journal, 2022, 33 : 493 - 505